NOV Inc.
NOV
$14.79
-$0.17-1.14%
Weiss Ratings | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C+ | |||
Rating Factors | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Fair | |||
Growth Index | Excellent | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.03 | |||
Price History | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.33% | |||
30-Day Total Return | -0.40% | |||
60-Day Total Return | -2.38% | |||
90-Day Total Return | -5.94% | |||
Year to Date Total Return | 0.61% | |||
1-Year Total Return | -16.57% | |||
2-Year Total Return | -35.44% | |||
3-Year Total Return | -33.90% | |||
5-Year Total Return | 34.33% | |||
52-Week High % Change | -29.43% | |||
52-Week Low % Change | 8.60% | |||
Price | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $21.20 | |||
52-Week Low Price | $13.78 | |||
52-Week Low Price (Date) | Mar 04, 2025 | |||
52-Week High Price (Date) | Jul 31, 2024 | |||
Valuation | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 5.70B | |||
Enterprise Value | 6.91B | |||
Price/Earnings (TTM) | 9.33 | |||
Earnings Per Share (TTM) | 1.60 | |||
Earnings Per Share Growth | -35.94% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.66 | |||
Price/Book (Q) | 0.90 | |||
Enterprise Value/Revenue (TTM) | 0.78 | |||
Price | $14.79 | |||
Enterprise Value/EBITDA (TTM) | 4.73 | |||
Enterprise Value/EBIT | 6.18 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 390.00M | |||
Dividend Yield | 1.84% | |||
Div. Per Share (Most Recent) | $0.08 | |||
Dividend Per Share (TTM) | $0.28 | |||
Payout Ratio (TTM) | 17.01% | |||
Dividend Per Share (Most Recent) | $0.08 | |||
Company Info | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 346 223 3000 | |||
Address | 10353 Richmond Avenue Houston, TX 77042-4103 | |||
Website | www.nov.com | |||
Country | United States | |||
Year Founded | 1862 | |||
Profitability | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 12.60% | |||
Profit Margin | 7.15% | |||
Management Effectiveness | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 6.17% | |||
Return on Equity | 10.02% | |||
Income Statement | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 8.87B | |||
Total Revenue (TTM) | 8.87B | |||
Revenue Per Share | $22.74 | |||
Gross Profit (TTM) | 2.25B | |||
EBITDA (TTM) | 1.46B | |||
EBIT (TTM) | 1.12B | |||
Net Income (TTM) | 635.00M | |||
Net Income Avl. to Common (TTM) | 635.00M | |||
Total Revenue Growth (Q YOY) | -1.49% | |||
Earnings Growth (Q YOY) | -72.94% | |||
EPS Diluted (TTM) | 1.60 | |||
EPS Diluted Growth (Q YOY) | -73.17% | |||
Balance Sheet | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.23B | |||
Cash Per Share (Q) | $3.15 | |||
Total Current Assets (Q) | 5.77B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 6.43B | |||
Current Ratio (Q) | 2.458 | |||
Book Value Per Share (Q) | $16.71 | |||
Total Assets (Q) | 11.36B | |||
Total Current Liabilities (Q) | 2.35B | |||
Total Debt (Q) | 2.39B | |||
Total Liabilities (Q) | 4.93B | |||
Total Common Equity (Q) | 6.38B | |||
Cash Flow | NOV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -471.00M | |||
Cash from Financing (TTM) | -406.00M | |||
Net Change in Cash (TTM) | 414.00M | |||
Levered Free Cash Flow (TTM) | 1.10B | |||
Cash from Operations (TTM) | 1.30B | |||